跳到正文

杨森制药的争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 3 条

  1. 2021

    涉及杨森的阿片类药物诉讼

    杨森被列为纽约州总检察长莱蒂蒂亚·詹姆斯提起的阿片类药物诉讼的被告。强生与纽约州达成和解,之后杨森被从案件中移除。

  2. 2019

    恩西尼塔斯市起诉阿片类药物制造商和分销商

    提起诉讼

    恩西尼塔斯市对阿片类药物行业的多家公司及相关方提起诉讼,指称制造商和分销商的行为导致医生开具相关药物,并忽视了向消费者警示其成瘾性。诉讼列明 Teva Pharmaceutical Industries USA Inc.、Janssen Pharmaceuticals Inc.、AmerisourceBergen Corp. 以及 Purdue Pharma 的所有者 Sackler 家族。

    当事方说明的目的. 追回该市及其居民因阿片类药物危机承担的费用和税收资源。

    来源摘录

    • The parties named in the suit include Teva Pharmaceutical Industries USA Inc., Janssen Pharmaceuticals Inc., the AmerisourceBergen Corp. and the Sackler family, the owners of oxycontin manufacturer Purdue Pharma.
    • The city of Encinitas announced Thursday that it filed a lawsuit against multiple companies and parties in the opioid manufacturing industry, arguing that the city is entitled to economic and health and welfare damages due to the ongoing opioid crisis.
    • “This lawsuit will seek to recover costs and tax resources taken from the City and its citizens due to the bad acts of the manufacturers and distributors of opioids who caused this ongoing crisis,” said Robins Kaplan attorney Roman Silberfeld.
  3. 2012

    维思通营销和回扣案

    美国司法部和州当局指控强生和杨森推广维思通用于未经批准的用途,包括用于老年患者,并提供与疗养院处方相关的不当付款或激励。该案导致多州和解以及刑事和民事处罚。